Assessment of mental disorders in vitiligo. Conduct in our daily practice

Affected body surface area (BSA) was calculated by considering the surface of palm as 1%. Diagnoses Frequency (%) General Psychiatric morbidity 48,33 Drug abuse 0,55 Anxiety disorder 21,66 Bullimia 1,11 Depression 11,11 Insomnia 33,33 Obsesive-Compulsive disorder 0,55 Trichotillomania 0,55 Table I. Prevalence of psychiatric conditions in the sample Diagnoses Female prevalence (%) Male prevalence (%) General Psychiatric morbidity 53 41,25 Drug abuse 0 1,25 Anxiety disorder 38 18,75 Bullimia 2 0 Depression 16 5 Insomnia 40 25 Trichotillomania 0 1,25 Behaviour disorder 0 1,25 Suicidal ideation 1 1,25 Table II. Not only cutaneous therapies and follow-up, but also specific measures of psycholgical variables and investigation of psychiatric morbidity (mainly sleeping disorders, anxiety and depression) should be included in our daily practice with vitiligo patients. 1.